proxyvotesnow.com

Home › Companies › Surgery Partners, Inc. › 2025-2026

Surgery Partners, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Surgery Partners, Inc.’s Form 8-K, filed 2026-06-05 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 5Ballot items
  • 206Asset managers
  • 1,188Fund votes
  • 2026-06-05Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Surgery Partners, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Surgery Partners, Inc.

These tallies are Surgery Partners, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Surgery Partners, Inc. — official shareholder meeting results, meeting held 2026-06-05
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Devin O'Reilly 90,059,419---- 23,613,7256,243,195 Majority: yes
Elect Director: Brent Turner 110,147,882---- 3,525,2626,243,195 Majority: yes
Elect Director: Laura L. Forese, M.D. 91,121,777---- 22,551,3676,243,195 Majority: yes
Proposal 2: Advisory vote on executive compensation 111,639,0922,018,77715,275 --6,243,195 Majority: yes
Proposal 3: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2026 119,828,74162,95024,648 ---- Majority: yes

Source: Surgery Partners, Inc., Form 8-K, filed with the SEC on 2026-06-05 — read the filing on EDGAR.

How asset managers voted at the Surgery Partners, Inc. 2025-2026 meeting

Each item below shows how the 206 asset managers that disclosed a Surgery Partners, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 111,639,092AGAINST: 2,018,777

Surgery Partners, Inc.’s own tally for this item (“Proposal 2: Advisory vote on executive compensation”): 111,639,092 for, 2,018,777 against, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,797,216 outstanding shares: 85% for, 2% against (87% of the company cast a for/against vote).

The 206 asset managers below cast 99.5% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 99.4%
FOR: 99.5%AGAINST: 0.5%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers.” at Surgery Partners, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BAIN CAPITAL INVESTORS LLC49,946,9720 00For
Janus Henderson27,023,4280 00For
JANUS INVESTMENT FUND12,979,6400 00For
OAK RIDGE INVESTMENTS LLC12,146,7110 00For
Pentwater Capital Management LP12,146,7110 00For
Vanguard7,532,1123 00For
T. Rowe Price4,186,3240 00For
Clearbridge Investments, LLC3,892,0080 00For
Legg Mason3,352,5800 00For
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP3,108,4380 00For
BlackRock2,777,0760 00For
Charles Schwab2,216,1790 00For
Fidelity2,016,2540 00For
GLENVIEW CAPITAL MANAGEMENT, LLC1,800,0000 00For
Sea Cliff Partners Management, LP1,039,7990 00For
GEODE CAPITAL MANAGEMENT, LLC998,7400 00For
RAYMOND JAMES & ASSOCIATES799,3260 00For
Irenic Capital Management LP0711,000 00Against
John Hancock673,3390 00For
State Street646,7270 00For
UBS630,5940 00For
Pacific Life555,2320 00For
Northern Trust364,7970 00For
Man Group plc270,8710 00For
Victory Capital269,1890 00For

Showing the 25 largest of 206 asset managers. See all 206 in the interactive database.

2. Election of Class II Directors: Devin O'Reilly

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD 21%
FOR: 90,059,419WITHHELD: 23,613,725

Surgery Partners, Inc.’s own tally for this item (“Elect Director: Devin O'Reilly”): 90,059,419 for, 23,613,725 withheld, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,797,216 outstanding shares: 69% for, 18% withheld (87% of the company cast a for/withheld vote).

The 60 asset managers below cast 100% of the shares they voted on this item FOR (28,028,553 for, 0 against).

FOR 92%8%
FOR: 28,028,553 (92.2%)ABSTAIN: 2,361,636 (7.8%)
Largest asset managers voting on “Election of Class II Directors: Devin O'Reilly” at Surgery Partners, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND12,979,6400 00For
Vanguard7,005,3430 10,9010For
Legg Mason3,352,5800 00For
T. Rowe Price00 1,688,1130Abstain
Fidelity1,330,7160 00For
Charles Schwab1,108,0790 00For
BlackRock943,4420 00For
Pacific Life555,2320 00For
Equitable163,5940 51,5080For
TIAA159,7970 00For
Principal Exchange-Traded Funds00 139,3740Abstain
WESMARK FUNDS00 120,0000Abstain
Lincoln Financial55,8020 27,1950For
Gabelli73,1970 00For
RBB FUND, INC.57,0740 00For
WisdomTree00 46,6180Abstain
Northern Lights Fund Trust IV43,4090 00For
QUANTITATIVE MASTER SERIES LLC40,8310 00For
First Trust00 40,7380Abstain
Global X00 36,1870Abstain
Bridge Builder Trust33,9840 00For
Goldman Sachs00 33,2680Abstain
JPMorgan31,5440 00For
GDL FUND28,0000 00For
FRANK FUNDS22,0000 00For

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

3. Election of Class II Directors: Brent Turner

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 110,147,882WITHHELD: 3,525,262

Surgery Partners, Inc.’s own tally for this item (“Elect Director: Brent Turner”): 110,147,882 for, 3,525,262 withheld, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,797,216 outstanding shares: 84% for, 3% withheld (87% of the company cast a for/withheld vote).

The 60 asset managers below cast 100% of the shares they voted on this item FOR (30,286,687 for, 0 against).

FOR 99.6%
FOR: 30,286,687 (99.7%)ABSTAIN: 103,502 (0.3%)
Largest asset managers voting on “Election of Class II Directors: Brent Turner” at Surgery Partners, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND12,979,6400 00For
Vanguard7,005,3750 10,8690For
Legg Mason3,352,5800 00For
T. Rowe Price1,687,7910 3220For
Fidelity1,330,7160 00For
Charles Schwab1,108,0790 00For
BlackRock943,4420 00For
Pacific Life555,2320 00For
Equitable163,5940 51,5080For
TIAA159,7970 00For
Principal Exchange-Traded Funds139,3740 00For
WESMARK FUNDS120,0000 00For
Lincoln Financial75,2830 7,7140For
Gabelli73,1970 00For
RBB FUND, INC.57,0740 00For
WisdomTree46,6180 00For
Northern Lights Fund Trust IV43,4090 00For
QUANTITATIVE MASTER SERIES LLC40,8310 00For
First Trust40,7380 00For
Global X36,1870 00For
Bridge Builder Trust33,9840 00For
Goldman Sachs33,2680 00For
JPMorgan31,5440 00For
GDL FUND28,0000 00For
FRANK FUNDS22,0000 00For

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

4. Election of Class II Directors: Laura L. Forese, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD 20%
FOR: 91,121,777WITHHELD: 22,551,367

Surgery Partners, Inc.’s own tally for this item (“Elect Director: Laura L. Forese, M.D.”): 91,121,777 for, 22,551,367 withheld, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,797,216 outstanding shares: 70% for, 17% withheld (87% of the company cast a for/withheld vote).

The 60 asset managers below cast 100% of the shares they voted on this item FOR (28,162,456 for, 0 against).

FOR 93%7%
FOR: 28,162,456 (92.7%)ABSTAIN: 2,227,733 (7.3%)
Largest asset managers voting on “Election of Class II Directors: Laura L. Forese, M.D.” at Surgery Partners, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND12,979,6400 00For
Vanguard7,016,2070 370For
Legg Mason3,352,5800 00For
T. Rowe Price00 1,688,1130Abstain
Fidelity1,330,7160 00For
Charles Schwab1,108,0790 00For
BlackRock943,4420 00For
Pacific Life555,2320 00For
Equitable163,5940 51,5080For
TIAA159,7970 00For
Principal Exchange-Traded Funds00 139,3740Abstain
WESMARK FUNDS00 120,0000Abstain
Lincoln Financial55,8020 27,1950For
Gabelli73,1970 00For
RBB FUND, INC.57,0740 00For
WisdomTree00 46,6180Abstain
Northern Lights Fund Trust IV43,4090 00For
QUANTITATIVE MASTER SERIES LLC40,8310 00For
First Trust00 40,7380Abstain
Global X36,1870 00For
Bridge Builder Trust33,9840 00For
Goldman Sachs33,2680 00For
JPMorgan31,5440 00For
GDL FUND28,0000 00For
FRANK FUNDS22,0000 00For

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

5. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 119,828,741AGAINST: 62,950

Surgery Partners, Inc.’s own tally for this item (“Proposal 3: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2026”): 119,828,741 for, 62,950 against, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,797,216 outstanding shares: 92% for, 0.1% against (92% of the company cast a for/against vote).

The 60 asset managers below cast 100% of the shares they voted on this item FOR (30,390,189 for, 0 against).

FOR 100%
FOR: 30,390,189 (100.0%)
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting” at Surgery Partners, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND12,979,6400 00For
Vanguard7,016,2440 00For
Legg Mason3,352,5800 00For
T. Rowe Price1,688,1130 00For
Fidelity1,330,7160 00For
Charles Schwab1,108,0790 00For
BlackRock943,4420 00For
Pacific Life555,2320 00For
Equitable215,1020 00For
TIAA159,7970 00For
Principal Exchange-Traded Funds139,3740 00For
WESMARK FUNDS120,0000 00For
Lincoln Financial82,9970 00For
Gabelli73,1970 00For
RBB FUND, INC.57,0740 00For
WisdomTree46,6180 00For
Northern Lights Fund Trust IV43,4090 00For
QUANTITATIVE MASTER SERIES LLC40,8310 00For
First Trust40,7380 00For
Global X36,1870 00For
Bridge Builder Trust33,9840 00For
Goldman Sachs33,2680 00For
JPMorgan31,5440 00For
GDL FUND28,0000 00For
FRANK FUNDS22,0000 00For

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

Largest Surgery Partners, Inc. shareholders voting in 2025-2026

Ranked by the number of Surgery Partners, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 130,797,216 shares outstanding at the time of that meeting.

Top Surgery Partners, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1BAIN CAPITAL INVESTORS LLC 38.19%
2Janus Henderson 20.66%
3JANUS INVESTMENT FUND 9.92%
4OAK RIDGE INVESTMENTS LLC 9.29%
5Pentwater Capital Management LP 9.29%
6Vanguard 5.76%
7T. Rowe Price 3.20%
8Clearbridge Investments, LLC 2.98%
9Legg Mason 2.56%
10DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 2.38%

Reported Surgery Partners, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Surgery Partners, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Bain Capital Investors, LLC 38.19% DEF14A
Janus Henderson Group PLC 9.97% DEF14A
Pentwater Capital Management LP 9.68% 13G
King Street Capital Management, L.P. 7.14% DEF14A
Vanguard Group 5.78% 13F
FMR LLC 5.00% DEF14A
BlackRock 4.33% 13F
Dimensional Fund Advisors 4.05% 13F
Citadel Advisors 1.72% 13F
FMR (Fidelity) 1.68% 13F

Percentages above are of 130,797,216 shares outstanding, as reported by Surgery Partners, Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Surgery Partners, Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Surgery Partners, Inc.'s shareholder meeting held 2026-06-05, in the 2025-2026 proxy season, 206 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,188 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation paid by the Company to its named executive… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Surgery Partners, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-05.

Surgery Partners, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).